A large, nationwide, longitudinal study of central nervous system diseases among Korean workers exposed to manganese

Parkinsonism and Related Disorders

Volumn 21, Issue 3, 2015, Pages 194-198

  Yoon, Jin Ha ^a   Ahn, Yeon Soon ^b  

^a Yonsei University College of Medicine   (South Korea)

^b Dongguk University Ilsan Hospital   (South Korea)

Author keywords

Central nervous system diseases; Degenerative nervous system diseases; Manganese; Occupational epidemiology; Parkinsonism

Indexed keywords

MANGANESE;

ADULT; ARTICLE; CENTRAL NERVOUS SYSTEM DISEASE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; EPIDEMIOLOGICAL DATA; EXTRAPYRAMIDAL SYMPTOM; HIGH RISK POPULATION; HOSPITAL ADMISSION; HUMAN; ICD-10; KOREAN (PEOPLE); LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MOTOR DYSFUNCTION; OCCUPATIONAL EXPOSURE; OCCUPATIONAL HAZARD; OCCUPATIONAL HEALTH; PARKINSONISM; PRIORITY JOURNAL; AGE DISTRIBUTION; CENTRAL NERVOUS SYSTEM DISEASES; COMPLICATION; FEMALE; HEALTH SURVEY; MANGANESE POISONING; MIDDLE AGED; MOVEMENT DISORDERS; SOUTH KOREA; STATISTICS AND NUMERICAL DATA; YOUNG ADULT;

ADULT; AGE DISTRIBUTION; CENTRAL NERVOUS SYSTEM DISEASES; FEMALE; HEALTH SURVEYS; HUMANS; LONGITUDINAL STUDIES; MALE; MANGANESE POISONING; MIDDLE AGED; MOVEMENT DISORDERS; OCCUPATIONAL EXPOSURE; REPUBLIC OF KOREA; YOUNG ADULT;

EID: 84923230030     PISSN: 13538020     EISSN: 18735126     Source Type: Journal    
DOI: 10.1016/j.parkreldis.2014.11.021     Document Type: Article

References (32)

1. Lees-Haley P.R., Rohling M.L., Langhinrichsen-Rohling J. Ameta-analysis of the neuropsychological effects of occupational exposure to manganese. Clin Neuropsychol 2006, 20:90-107.
2. Haynes E.N., Heckel P., Ryan P., Roda S., Leung Y.K., Sebastian K., et al. Environmental manganese exposure in residents living near a ferromanganese refinery in Southeast Ohio: a pilot study. Neurotoxicology 2010, 31:468-474.
3. Zoni S., Albini E., Lucchini R. Neuropsychological testing for the assessment of manganese neurotoxicity: a review and a proposal. Am J Ind Med 2007, 50:812-830.
4. Drown D.B., Oberg S.G., Sharma R.P. Pulmonary clearance of soluble and insoluble forms of manganese. JToxicol Environ Health 1986, 17:201-212.
5. Jiang Y.M., Mo X.A., Du F.Q., Fu X., Zhu X.Y., Gao H.Y., et al. Effective treatment of manganese-induced occupational Parkinsonism with p-aminosalicylic acid: a case of 17-year follow-up study. JOccup Environ Med 2006, 48:644-649.
6. Crossgrove J., Zheng W. Manganese toxicity upon overexposure. NMR Biomed 2004, 17:544-553.
7. Beuter A., Edwards R., deGeoffroy A., Mergler D., Hundnell K. Quantification of neuromotor function for detection of the effects of manganese. Neurotoxicology 1999, 20:355-366.
8. Bowler R.M., Gysens S., Diamond E., Nakagawa S., Drezgic M., Roels H.A., et al. Manganese exposure: neuropsychological and neurological symptoms and effects in welders. Neurotoxicology 2006, 27:315-326.
9. Lucchini R., Albini E., Benedetti L., Alessio L. Neurobehavioral science in hazard identification and risk assessment of neurotoxic agents-what are the requirements for further development?. Int Arch Occup Environ Health 2005, 78:427-437.
10. Fored C.M., Fryzek J.P., Brandt L., Nise G., Sjogren B., McLaughlin J.K., et al. Parkinson's disease and other basal ganglia or movement disorders in a large nationwide cohort of Swedish welders. Occup Environ Med 2006, 63:135-140.
11. Park J., Yoo C.I., Sim C.S., Kim J.W., Yi Y., Shin Y.C., et al. Aretrospective cohort study of Parkinson's disease in Korean shipbuilders. Neurotoxicology 2006, 27:445-449.
12. Fryzek J.P., Hansen J., Cohen S., Bonde J.P., Llambias M.T., Kolstad H.A., et al. Acohort study of Parkinson's disease and other neurodegenerative disorders in Danish welders. JOccup Environ Med 2005, 47:466-472.
13. Kenborg L., Lassen C.F., Hansen J., Olsen J.H. Parkinson's disease and other neurodegenerative disorders among welders: a Danish cohort study. Mov Disord 2012, 27:1283-1289.
14. Kim E.A., Kang S.K. Occupational neurological disorders in Korea. JKorean Med Sci 2010, 25:S26-S35.
15. Bowler R.M., Nakagawa S., Drezgic M., Roels H.A., Park R.M., Diamond E., et al. Sequelae of fume exposure in confined space welding: a neurological and neuropsychological case series. Neurotoxicology 2007, 28:298-311.
16. Levy B.S., Nassetta W.J. Neurologic effects of manganese in humans: a review. Int J Occup Environ Health 2003, 9:153-163.
17. Myers J.E., Thompson M.L., Ramushu S., Young T., Jeebhay M.F., London L., et al. The nervous system effects of occupational exposure on workers in a South African manganese smelter. Neurotoxicology 2003, 24:885-894.
18. Lucchini R., Apostoli P., Perrone C., Placidi D., Albini E., et al. Long-term exposure to "low levels" of manganese oxides and neurofunctional changes in ferroalloy workers. Neurotoxicology 1999, 20:287-297.
19. Kim Y. Health effects of manganese and some recent issues in manganese neurotoxicity research. Korean J Occup Environ Med 2009, 21:87-105.
20. Calne D.B., Chu N.S., Huang C.C., Lu C.S., Olanow W. Manganism and idiopathic parkinsonism: similarities and differences. Neurology 1994, 44:1583-1586.
21. Takeda A. Manganese action in brain function. Brain Res Brain Res Rev 2003, 41:79-87.
22. Leung M.C., Williams P.L., Benedetto A., Au C., Helmcke K.J., Aschner M., et al. Caenorhabditis elegans: an emerging model in biomedical and environmental toxicology. Toxicol Sci 2008, 106:5-28.
23. Finkelstein M.M., Jerrett M. Astudy of the relationships between Parkinson's disease and markers of traffic-derived and environmental manganese air pollution in two Canadian cities. Environ Res 2007, 104:420-432.
24. Malecki E.A. Manganese toxicity is associated with mitochondrial dysfunction and DNA fragmentation in rat primary striatal neurons. Brain Res Bull 2001, 55:225-228.
25. Daviglus M.L., Plassman B.L., Pirzada A., Bell C.C., Bowen P.E., Burke J.R., et al. Risk factors and preventive interventions for Alzheimer disease: state of the science. Arch Neurol 2011, 68:1185-1190.
26. Gonzalez-Dominguez R., Garcia-Barrera T., Gomez-Ariza J.L. Characterization of metal profiles in serum during the progression of Alzheimer's disease. Metallomics 2014, 6:292-300.
27. Marrie R.A. Environmental risk factors in multiple sclerosis aetiology. Lancet Neurol 2004, 3:709-718.
28. Landtblom A.M., Flodin U., Soderfeldt B., Wolfson C., Axelson O. Organic solvents and multiple sclerosis: a synthesis of the current evidence. Epidemiology 1996, 7:429-433.
29. Malek A.M., Barchowsky A., Bowser R., Heiman-Patterson T., Lacomis D., Rana S., et al. Environmental and occupational risk factors for amyotrophic lateral sclerosis: a case-control study. Neurodegener Dis 2014, 14:31-38.
30. Park B. Report on accuracy of disease coding in national health insurance claim data (Korean) 2002, Seoul National University, School of Medicine, Seoul.
31. Ahn Y.S., Park R.M., Koh D.H. Cancer admission and mortality in workers exposed to ionizing radiation in Korea. JOccup Environ Med 2008, 50:791-803.
32. Satake W., Nakabayashi Y., Mizuta I., Hirota Y., Ito C., Kubo M., et al. Genome-wide association study identifies common variants at four loci as genetic risk factors for Parkinson's disease. Nat Genet 2009, 41:1303-1307.